The PP-MSA criteria demonstrate high sensitivity but limited specificity in patients with PAF and a stricter olfactory threshold improves diagnostic performance and may enhance cohort enrichment for clinical trials.
Patricio Millar Vernetti, J. Palma, I. Biaggioni et al.· Movement Disorders· 1 citation
Bridging advances in pathophysiology with patient-centred care will be essential for improving outcomes in MSA, and advances in fluid biomarkers and multimodal imaging are expected to facilitate earlier detection, improve diagnostic accuracy, and provide more robust tools for monitoring disease progression.
J. Buonocore, Bianca Calió, Fabian Leys et al.· Journal of neural transmissi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.